| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
6 |
/ |
2023 |
|
|
|
| |
Data sporządzenia: |
2023-05-10 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Successful completion of epidural steroid injections _ESI_ using the CompuFlo Epidural
System Under New AMA CPT Guidelines for Artificial Intelligence _AI_ Assisted Pain
Management Surgery
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced the successful completion of the first series of epidural steroid
injections _ESI_ using the CompuFlo Epidural System by physicians under the new American
Medical Association _AMA_ Current Procedural Terminology _CPT_ guidelines for AI-assisted
analgesic epidural needle placement in patients.
The AMA's new technology-specific Category III CPT code, which came into effect in
the CPT codebook on January 1, 2023, specifically covers technologies that "integrate
AI to place an epidural needle." The published and copyrighted guidelines further
note that the technology must include real-time software to assist the physician by
transmitting key data points, along with sensors to interpret epidural pressures,
detail anatomical needle placement, and measure precise saline volume via software
facilitating data transmission to an epidural system console screen. The Board of
Directors of the Company is not aware of any systems, other than the CompuFlo Epidural
System, that would meet these criteria. Additionally, the technology is backed by
a broad portfolio of domestic and international patents.
The Board of Directors of the Company is proud to announce that multiple physicians
have now completed ESI procedures using the CompuFlo Epidural System under the new
AMA CPT guidelines for AI-assisted epidural needle placement. This is an important
milestone, as it further validates the medical importance of the CompuFlo Epidural
System by these physicians in their plans of treatment. Specifically, the Company'
proprietary and highly accurate AI-assisted technology enhances both the efficacy
and safety of pain management surgery. The Board of Directors of the Company believes
that this data will play an important role as the Company seeks reimbursement for
the CompuFlo Epidural System under the new CPT code.
|
|
|
RB_ASO: Successful completion of epidural steroid injections (ESI) using the CompuFlo Epidural
System Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain
Management Surgery
